E-LIB Suche - Ergebnisse für: Kenji Tsuchihashi

1

Effectiveness and safety of primary prophylaxis of granuloc..:

Uchino, Keita ; Tamura, Shingo ; Kimura, Shoji...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 545-550 , 2024

Link: https://doi.org/10.1007/..

2

Effectiveness and safety of primary prophylaxis of G-CSF du..:

Kimura, Shoji ; Shigeta, Keisuke ; Tamura, Shingo...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 559-563 , 2024

Link: https://doi.org/10.1007/..

3

Therapeutic use of granulocyte colony-stimulating factor (G..:

Tsuchihashi, Kenji ; Ito, Mamoru ; Okumura, Yuta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 700-705 , 2024

Link: https://doi.org/10.1007/..

4

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1081-1087 , 2024

Link: https://doi.org/10.1007/..

5

Primary prophylaxis with G-CSF for patients with non-round ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1067-1073 , 2024

Link: https://doi.org/10.1007/..

6

Optimal timing of prophylactic pegylated G-CSF after chemot..:

Ozaki, Yukinori ; Yokoe, Takamichi ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 551-558 , 2024

Link: https://doi.org/10.1007/..

7

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Maeda, Tomoya ; Najima, Yuho ; Kamiyama, Yutaro...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 535-544 , 2024

Link: https://doi.org/10.1007/..

8

Effectiveness and safety of granulocyte colony-stimulating ..:

Najima, Yuho ; Maeda, Tomoya ; Kamiyama, Yutaro...
International Journal of Clinical Oncology. 29 (2024) 7 - p. 899-910 , 2024

Link: https://doi.org/10.1007/..

9

Epithelioid hemangioendothelioma—its history, clinical feat..:

Tsuchihashi, Kenji ; Baba, Eishi
Japanese Journal of Clinical Oncology. 54 (2024) 7 - p. 739-747 , 2024

Link: https://doi.org/10.1093/..

10

Comparison between a single dose of PEG G-CSF and multiple ..:

Yoshinami, Tetsuhiro ; Nozawa, Kazuki ; Yokoe, Takamichi...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 681-688 , 2024

Link: https://doi.org/10.1007/..

11

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Ichihara, Eiki ; Ochi, Nobuaki ; Makimoto, Go...
International Journal of Clinical Oncology. 29 (2024) 4 - p. 355-362 , 2024

Link: https://doi.org/10.1007/..

12

Effectiveness of G-CSF in chemotherapy for digestive system..:

Ito, Mamoru ; Okumura, Yuta ; Nio, Kenta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 689-699 , 2024

Link: https://doi.org/10.1007/..

13

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Nozawa, Kazuki ; Ozaki, Yukinori ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1074-1080 , 2024

Link: https://doi.org/10.1007/..

14

Phase II Trial of Nivolumab in Metastatic Rare Cancer with ..:

Okuma, Hitomi S. ; Watanabe, Keisuke ; Tsuchihashi, Kenji...
Clinical Cancer Research. 29 (2023) 24 - p. 5079-5086 , 2023

Link: https://doi.org/10.1158/..

15

Preferential B cell differentiation by combined immune chec..:

Uehara, Koki ; Tanoue, Kenro ; Yamaguchi, Kyoko...
Cancer Immunology, Immunotherapy. 72 (2023) 11 - p. 3543-3558 , 2023

Link: https://doi.org/10.1007/..